The 4NQO-induced carcinogenesis model closely mimics the histopathological features of human HNSCC, providing a robust approach for investigating whether AOH1996 treatment could eliminate CSCs and synergize with anti-PD1 immunotherapy (Fig. 4A). This evidence concerns the gene PDCD1 and head and neck squamous cell carcinoma.